Telemetry Investments’s Syndax Pharmaceuticals SNDX Stock Holding History

Telemetry Investments’s Portfolio SNDX Stock Details SNDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-10,000	Closed	-$174K	–	186
2022 Q1	$174K	Buy	+10,000	New	+$168K	0.27%	98
2019 Q4	–	Sell	-13,000	Closed	-$97K	–	50
2019 Q3	$97K	Buy	+13,000	New	+$118K	0.28%	50
2019 Q2	–	Sell	-25,000	Closed	-$131K	–	108
2019 Q1	$131K	Sell	25,000 -25,000	-50%	-$143K	0.07%	87
2018 Q4	$222K	Buy	50,000 +26,947	+117%	+$148K	0.14%	109
2018 Q3	$186K	Sell	23,053 -25,947	-53%	-$185K	0.08%	101
2018 Q2	$344K	Buy	+49,000	New	+$481K	0.13%	77

Other funds holding SNDX

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Telemetry Investments's SNDX Position: Q2 2022 in Review

Telemetry Investments sold out of Syndax Pharmaceuticals (SNDX) in Q2 2022, closing a stake of 10,000 shares — an estimated $174K sold.

Telemetry Investments first reported a position in SNDX in Q2 2018 and held it in 6 quarters. The position peaked at $344K in Q2 2018. 121 funds tracked by Wall St. Rank hold SNDX as of Q2 2022.

Telemetry Investments reported no remaining Syndax Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
Telemetry Investments sold 10,000 Syndax Pharmaceuticals shares in Q2 2022, an estimated $174K.
Telemetry Investments first reported a position in Syndax Pharmaceuticals in Q2 2018 and held it in 6 quarters.
Telemetry Investments's Syndax Pharmaceuticals position peaked at $344K in Q2 2018.
121 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q2 2022.

Based on Telemetry Investments's 13F filing for Q2 2022, filed 15 Aug 2022.